NanoViricides, Inc. (NNVC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NNVC Revenue Growth
NNVC Revenue Analysis (2014–2025)
As of May 8, 2026, NanoViricides, Inc. (NNVC) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q2 2026) recorded $0 in revenue.
Looking at the longer-term picture, NNVC's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including SIGA (-22.1% YoY), GILD (+3.5% YoY), and ABBV (+8.6% YoY). Compare NNVC vs SIGA →
NNVC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NNVCCurrent | $0 | - | - | - | |
 SIGA | $95M | -22.1% | -5.4% | 25.1% | |
 GILD | $29.4B | +3.5% | +3.6% | 40.1% | |
 ABBV | $61.2B | +8.6% | +6.0% | 32.8% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% |
NNVC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-9,591,645 | - |
| 2024 | $0 | - | $0 | - | $-8,516,111 | - |
| 2023 | $0 | - | $0 | - | $-8,943,468 | - |
| 2022 | $0 | - | $0 | - | $-8,113,599 | - |
| 2021 | $0 | - | $0 | - | $-8,744,106 | - |
| 2020 | $0 | - | $0 | - | $-7,996,459 | - |
| 2019 | $0 | - | $-695,911 | - | $-8,659,682 | - |
| 2018 | $0 | - | $-680,058 | - | $-9,325,169 | - |
| 2017 | $0 | - | $-662,954 | - | $-9,600,724 | - |
| 2016 | $0 | - | $-659,545 | - | $-8,859,501 | - |
See NNVC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NNVC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NNVC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNNVC — Frequently Asked Questions
Quick answers to the most common questions about buying NNVC stock.
Is NNVC's revenue growth accelerating or slowing?
NNVC TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NNVC's long-term revenue growth rate?
NanoViricides, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is NNVC's revenue distributed by segment?
NNVC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.